Industrial, Manufacturing & Heavy Industry Market News

Cancer supportive care products market valued at nearly CAGR of 4.5% in 2024 according to new research report

Industrial Market Research

The new report of healthcare industry “Global Cancer Supportive Care Products Market” accounted to USD 25.4 billion in 2016 growing at a CAGR of 4.5% during the forecast period of 2017 to 2024.

Report Segmentation

Global Cancer Supportive Care Products Market By Cancer (Lung Cancer, Liver Cancer, Breast Cancer, Leukemia, Prostate Cancer, Ovarian Cancer, Bladder Cancer); By Therapeutic Area (Oral Mucositis And Dry Mouth, Chemotherapy Induced Nausea And Vomiting Cancer Pain, Chemotherapy Induced Anemia, Chemotherapy Induced Neutropenia, Bone Metastases); End-Users (Hospital Pharmacies, Retail Pharmacies, Compounding Pharmacies); Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa)- Industry Trends and Forecast to 2024

This report consists of below pages:

  • No of pages: 350
  • No of Figures: 60
  • No of Tables: 220


Cancer supportive care products have its applications in prevention and treatment of symptoms of cancer and the side-effects caused due to cancer therapy. Cancer supportive care products are used for treatment of the side-effects of chemotherapy such as bone metastasis, cancer pain, oral mucositis, neutropenia, nausea and vomiting, anemia among others.

Cancer Supportive Care Products Market Segmentation:

  • By drug class the market for cancer supportive care products market is segmented into nonsteroidal anti-inflammatory drugs, anti-infective, anti-emetics, monoclonal antibodies, erythropoietin stimulating agents, opioid analgesics, and bisphosphonates. By cancer type the cancer supportive care products market is segmented into lung cancer, liver cancer, breast cancer, leukemia, prostate cancer, ovarian cancer, bladder cancer, others.
  • On the basis of therapeutic area the market is segmented into oral mucositis and dry mouth, chemotherapy induced nausea and vomiting cancer pain, chemotherapy induced anemia, and chemotherapy induced neutropenia, bone metastases. On the basis of end-users the cancer supportive care products market is segmented into direct and retail.
  • On the basis of end-users the cancer supportive care products market is segmented into hospitals, clinic and ambulatory centers.


  • On the basis of geography, cancer supportive care products market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.

Cancer Supportive Care Products Market Competitive Analysis:

The global cancer supportive care products market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market.

The report includes market shares of cancer supportive care products market for global, Europe, North America, Asia Pacific and South America.

Some of the major players operating in cancer supportive care products market are Amgen Inc., Johnson & Johnson, Novartis Ag., Baxter International Inc, Fagron Group BV, Teva Pharmaceuticals Industries Ltd, Hoffmann LA- Roche Ltd, APR Applied Pharma Science Research S.A., Acacia Pharma Ltd, and Kyowa Hakko Kirin Co Ltd., Bayer, Heron Therapeutics, Insys Therapeutics, Kyowa Hakko Kirin, Daiichi Sankyo, Fagron Group BV, Teva Pharmaceuticals Industries Ltd., Acacia Pharma Ltd. among others.

Major Market Drivers and Restraints:

  • Increasing incidences of cancer
  • R&D investments by manufacturers to innovate supportive care products, drugs and vaccines
  • Rising demand of erythropoietin stimulating agents
  • Weak reimbursements

Read more about the Global Cancer Supportive Care Products Market at:…-products-market/


News From

Data Bridge Market ResearchData Bridge Market Research
Category: Market Research Publishers and RetailersCompany about: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...
This email address is being protected from spambots. You need JavaScript enabled to view it.